Logan R. J. Bailey

Logan R. J. Bailey

Auto-generated profile, based on publicly available information

Logan R. J. Bailey

Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2017 in Science
Verified
Journal Article
Closed access
PDF file
HRH. B. D. Prasada Rao
H. B. D. Prasada Rao
HQHuanyu Qiao
Huanyu Qiao
SBShubhang K. Bhatt
Shubhang K. Bhatt
LBLogan R. J. Bailey
Logan R. J. Bailey
HTHung D. Tran
Hung D. Tran
NHNeil Hunter
Neil Hunter
Proteasomes and SUMO wrestle chromosomes: Meiosis is the double cell division that generates haploid gametes from diploid parental cells. Pairing of homologous chromosomes during the first meiotic division ensures that each gamete receives a complete set of chromosomes. The proteasome, on the other hand, is a molecular machine that degrades proteins tagged for destruction within the cell (see the Perspective by Zetka). Ahuja et al. show that the proteasome is also involved in ensuring that homologous chromosomes pair with each other during meiosis. Rao et al. show that the SUMO (small ubiquitin-like modifier) protein, ubiquitin, and the proteasome localize to the axes between homologous chromosomes. In this location, they help mediate chromosome pairing and recombination between homologs. Science , this issue p. 349 , p. 408 ; see also p. 403

4 June 2024 in Circulation
Verified
Journal Article
Closed access
LBLogan R.J. Bailey
Logan R.J. Bailey
DBDarrian Bugg
Darrian Bugg
IRIsabella M. Reichardt
Isabella M. Reichardt
COC. Dessirée Ortaç
C. Dessirée Ortaç
ANAbigail Nagle
Abigail Nagle
JDJennifer Davis
Jennifer Davis
BACKGROUND: Discovering determinants of cardiomyocyte maturity is critical for deeply understanding the maintenance of differentiated states and potentially reawakening endogenous regenerative programs in adult mammalian hearts as a therapeutic strategy. Forced dedifferentiation paired with oncogene expression is sufficient to drive cardiac regeneration, but elucidation of endogenous developmental regulators of the switch between regenerative and mature cardiomyocyte cell states is necessary for optimal design of regenerative approaches for heart disease. MBNL1 (muscleblind-like 1) regulates fibroblast, thymocyte, and erythroid differentiation and proliferation. Hence, we examined whether MBNL1 promotes and maintains mature cardiomyocyte states while antagonizing cardiomyocyte proliferation. METHODS: MBNL1 gain- and loss-of-function mouse models were studied at several developmental time points and in surgical models of heart regeneration. Multi-omics approaches were combined with biochemical, histological, and in vitro assays to determine the mechanisms through which MBNL1 exerts its effects. RESULTS: MBNL1 is coexpressed with a maturation-association genetic program in the heart and is regulated by the MEIS1/calcineurin signaling axis. Targeted MBNL1 overexpression early in development prematurely transitioned cardiomyocytes to hypertrophic growth, hypoplasia, and dysfunction, whereas loss of MBNL1 function increased cardiomyocyte cell cycle entry and proliferation through altered cell cycle inhibitor transcript stability. Moreover, MBNL1-dependent stabilization of estrogen-related receptor signaling was essential for maintaining cardiomyocyte maturity in adult myocytes. In accordance with these data, modulating MBNL1 dose tuned the temporal window of neonatal cardiac regeneration, where increased MBNL1 expression arrested myocyte proliferation and regeneration and MBNL1 deletion promoted regenerative states with prolonged myocyte proliferation. However, MBNL1 deficiency was insufficient to promote regeneration in the adult heart because of cell cycle checkpoint activation. CONCLUSIONS: Here, MBNL1 was identified as an essential regulator of cardiomyocyte differentiated states, their developmental switch from hyperplastic to hypertrophic growth, and their regenerative potential through controlling an entire maturation program by stabilizing adult myocyte mRNAs during postnatal development and throughout adulthood. Targeting loss of cardiomyocyte maturity and downregulation of cell cycle inhibitors through MBNL1 deletion was not sufficient to promote adult regeneration.

4 October 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
JBJulie Bossuyt
Julie Bossuyt
JBJohanna M. Borst
Johanna M. Borst
MVMarie Verberckmoes
Marie Verberckmoes
LBLogan R. J. Bailey
Logan R. J. Bailey
DBDonald Bers
Donald Bers
BHBence Hegyi
Bence Hegyi
Background: Structural and electrophysiological remodeling characterize heart failure (HF) enhancing arrhythmias. PKD1 (protein kinase D1) is upregulated in HF and mediates pathological hypertrophic signaling, but its role in K+ channel remodeling and arrhythmogenesis in HF is unknown. Methods and Results: We performed echocardiography, electrophysiology, and expression analysis in wild‐type and PKD1 cardiomyocyte‐specific knockout (cKO) mice following transverse aortic constriction (TAC). PKD1‐cKO mice exhibited significantly less cardiac hypertrophy post‐TAC and were protected from early decline in cardiac contractile function (3 weeks post‐TAC) but not the progression to HF at 7 weeks post‐TAC. Wild‐type mice exhibited ventricular action potential duration prolongation at 8 weeks post‐TAC, which was attenuated in PKD1‐cKO, consistent with larger K+ currents via the transient outward current, sustained current, inward rectifier K+ current, and rapid delayed rectifier K+ current and increased expression of corresponding K+ channels. Conversely, reduction of slowly inactivating K+ current was independent of PKD1 in HF. Acute PKD inhibition slightly increased transient outward current in TAC and sham wild‐type myocytes but did not alter other K+ currents. Sham PKD1‐cKO versus wild‐type also exhibited larger transient outward current and faster early action potential repolarization. Tachypacing‐induced action potential duration alternans in TAC animals was increased and independent of PKD1, but diastolic arrhythmogenic activities were reduced in PKD1‐cKO. Conclusions: Our data indicate an important role for PKD1 in the HF‐related hypertrophic response and K+ channel downregulation. Therefore, PKD1 inhibition may represent a therapeutic strategy to reduce hypertrophy and arrhythmias; however, PKD1 inhibition may not prevent disease progression and reduced contractility in HF.

6 November 2025 in Science
Verified
Journal Article
Closed access
RBRoss C. Bretherton
Ross C. Bretherton
IRIsabella M. Reichardt
Isabella M. Reichardt
KZKristin A. Zabrecky
Kristin A. Zabrecky
ANAbigail Nagle
Abigail Nagle
LBLogan R. J. Bailey
Logan R. J. Bailey
JDJennifer Davis
Jennifer Davis
Cardiomyocyte hypocontractility underlies inherited dilated cardiomyopathy (DCM). Yet, whether fibroblasts modify DCM phenotypes remains unclear despite their regulation of fibrosis, which strongly predicts disease severity. Expression of a hypocontractility-linked sarcomeric variant in mice triggered cardiac fibroblast expansion from the de novo formation of hyperproliferative mechanosensitized fibroblast states, which occurred prior to eccentric myocyte remodeling. Initially, this fibroblast response reorganized fibrillar collagen and stiffened the myocardium, albeit without depositing fibrotic tissue. These adaptations coincided with heightened matrix–integrin receptor interactions and diastolic tension sensation at focal adhesions within fibroblasts. Targeted p38 deletion arrested these cardiac fibroblast responses in DCM mice, which prevented cardiomyocyte remodeling and improved contractility. p38-mediated fibroblast responses were essential regulators of DCM severity, marking a potential cellular target for therapeutic intervention.

1 February 2026 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
BHBence Hegyi
Bence Hegyi
LBLogan R. J. Bailey
Logan R. J. Bailey
JHJuliana Mira Hernandez
Juliana Mira Hernandez
CKChristopher Y. Ko
Christopher Y. Ko
ESErin Y. Shen
Erin Y. Shen
DBDonald Bers
Donald Bers
Excitation-Ca 2+ signaling-contraction coupling (ECC) mechanisms are fundamental to heart function. ECC mechanisms are differentially altered in murine models of heart failure with preserved ejection fraction (HFpEF) by dominant disease pathology and sex. Diastolic dysfunction is more pronounced in diabetic-obese HFpEF mice (worse in females) than in hypertensive-obese HFpEF mice (female sex is protective). Diabetic-obese mice and primarily hypertensive-obese HFpEF mice exhibit differential ECC alterations and largely distinctive transcription changes, providing mechanistic insights into HFpEF sub-phenogroups.

1 February 2019 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
BHBence Hegyi
Bence Hegyi
JBJohanna M. Borst
Johanna M. Borst
ALAusten J. Lucena
Austen J. Lucena
LBLogan R.J. Bailey
Logan R.J. Bailey
JBJulie Bossuyt
Julie Bossuyt
DBDonald M. Bers
Donald M. Bers